News

DSM reports 11% underlying organic growth

17 May 2018

DSM has announced its 1Q18 results. The company says it saw continued strong organic sales growth in underlying business, estimated at 11%, with adjusted EBITDA growth of underlying business estimated at 8%.

DSM reports 11% underlying organic growth

DSM has announced its 1Q18 results. The company says it saw continued strong organic sales growth in underlying business, estimated at 11%, with adjusted EBITDA growth of underlying business estimated at 8%, despite significant FX headwind. Total Adjusted EBITDA was up 56% and net profit up 122% to €331m. An increased full year outlook was confirmed.

Feike Sijbesma, CEO/Chairman DSM Managing Board, commented: “We are very pleased that the strong underlying performance of our business continues, with growth well above market. In addition, we are currently benefitting from substantially higher prices in some vitamins due to exceptional supply disruptions in the industry, which are expected to be temporary and heavily weighted towards the first half of the year. These two combined resulted in a significantly higher outlook for the full year 2018, which we announced with our preliminary Q1 2018 results on 12 April 2018.”